LONDON--(BUSINESS WIRE)--London, UK. 3-5 March 2015. The 5th Appel Biosimilars Conference brings together over 200 representers of leading pharmaceutical organisations, global biotechnology companies and internationally renowned academic institutions.
The 3-day pharmaceutical conference provides an opportunity for networking and cooperation through 60 presentations, case studies, workshops and panel discussions focused on the key issues in follow-on biologics development and corporate business strategy.The conference will consist of 4 main streams.
WHEN: Tuesday 3rd of March 2015 - Thursday 5th of March 2015
WHERE: Novotel London Greenwich Hotel 173-185, Greenwich High Rd, London, SE10 8JA
According to market research report, 'PharmaSphere: Global Biosimilars Strategy - Regulatory Landscape, Key Drivers, Markets and Trends in 2013' published by GlobalData, the global biosimilars market is expected to be worth $168 billion by 2017.
The growing dependence on biologics to provide significant benefits in the effective treatment of chronic diseases such as rheumatoid arthritis, psoriasis, cancer, Crohn's Disease and similar conditions has resulted in the continued increase in sales, generating over $128 billion in 2012 alone. This trend is expected to continue in the short term, growing by a Compound Annual Growth Rate (CAGR) of about 5.6% to reach over $168 billion by 2017. Afterwards, patent expirations and the existence of clearer regulatory frameworks for biosimilars will result in an upsurge of biosimilars in key biologics markets such as the US, having an adverse effect on global branded biologic sales. More information is available at www.appelconsulting.co.uk/.
About Appel Consulting
Appel Consulting is an independent information provider spanning many international leading professional industries from the Pharmaceutical Sector right through to Aviation. We organise professional international Conferences, Expos and Summits and also provide consultancy services bringing together a strong team with over 20 years of experience spanning over several sectors.
We offer a full range of conferences, from Renewable Energy to Vaccine Research.